The deficiency of Maged1 attenuates Parkinson's disease progression in mice
Abstract Melanoma-associated antigen D1 (Maged1) has critical functions in the central nervous system in both developmental and adult stages. Loss of Maged1 in mice has been linked to depression, cognitive disorder, and drug addiction. However, the role of Maged1 in Parkinson’s disease (PD) remains...
Main Authors: | Jie Wang, Sheng-Ye Xu, Zhi-Yuan Ye, Zhou-Na Sun, Jia-Qi Zhang, Cui Qi, Rui Liu, Xiang Gao, Chuan He, Wei-Yan You, Jun Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Molecular Brain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13041-023-01011-3 |
Similar Items
-
Height and nigral neuron density in Parkinson’s disease
by: Laura Saari, et al.
Published: (2022-07-01) -
The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson’s Disease
by: Tingting Liu, et al.
Published: (2023-12-01) -
Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease
by: Xingxing Jian, et al.
Published: (2022-01-01) -
Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson’s Disease: A Diffusion Tensor Imaging Study
by: Niels Bergsland, et al.
Published: (2021-11-01) -
Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats
by: M. Sofiabadi, et al.
Published: (2015-06-01)